1083P KEYMAKER 02B: A randomized trial of pembrolizumab (pembro) alone or with investigational agents as first-line treatment for advanced melanoma

Authors: Dummer, R., Shapira, R., Pigozzo, J., Ascierto, P.A., Gaudy Marqueste, C., Portnoy, D., Del Vecchio, M., Bar-Sela, G., Cohen, J.E., Di Giacomo, A.M., Ribas, A., Dutriaux, C., Belli, C., Cohen, G., Dokhan, R., Jing, N., Lal, R., Krepler, C., Long, G.V.

Source: In Annals of Oncology September 2024 35 Supplement 2:S717-S718

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

Synthesis and binding affinities of a series of 1,2-benzisoxazole-3-carboxamides to dopamine and serotonin receptors

Authors: Nuhrich, A, Varache-Lembège, M, Vercauteren, J, Dokhan, R, Renard, P, Devaux, G

Source: In European Journal of Medicinal Chemistry 1996 31(12):957-964

New N-(benzhydryloxyalkyl)-4-(carboxy/carbamoylmethyl) piperidine derivatives with antidepressant activity

Authors: El Ahmad, Y, Maillet, P, Laurent, E, Talab, A, Teste, JF, Cédat, MJ, Fiez-Vandal, PY, Dokhan, R, Ollivier, R

Source: In European Journal of Medicinal Chemistry 1997 32(3):205-218

ChemInform Abstract: New N-(Benzhydryloxyalkyl)-4-(carboxy/carbamoylmethyl)piperidine Derivatives with Antidepressant Activity.

Authors: EL AHMAD, Y., MAILLET, P., LAURENT, E., TALAB, A., TESTE, J. F., CEDAT, M. J., FIEZ-VANDAL, P. Y., DOKHAN, R., OLLIVIER, R.

Source: ChemInform; Aug1997, Vol. 28 Issue 33, pno-no, 1p

ChemInform Abstract: New Benzocycloalkylpiperazines, Potent and Selective 5-HT1A Receptor Ligands.

Authors: EL AHMAD, Y., LAURENT, E., MAILLET, P., TALAB, A., TESTE, J. F., DOKHAN, R., TRAN, G., OLLIVIER, R.

Source: ChemInform; Jun1997, Vol. 28 Issue 25, pno-no, 1p

This result is not displayed to guests.
Login for full access.